Antoniv A. A.


About the author:

Antoniv A. A.



Type of article:

Scentific article


The aim of the study – to find out the features of the lipid blood spectrum and the development of endothelial dysfunction in non-alcoholic steatohepatitis in patients with obesity and chronic kidney disease. Object and methods of research. 135 patients were examined: of which 52 patients with non-alcoholic steatohepatitis with obesity I degree (1 group), 53 patients with non-alcoholic steatohepatitis with comorbid obesity of the I degree and chronic kidney disease of the І-ІІ stage (group 2). The control group consisted of 30 practically healthy persons of the corresponding age and sex. The average age of patients was (45.8 ± 3.81) years, men were 48, and women 57 persons. Results of research and their discussion. As a result of studies, it was found that patients with non-alcoholic steatohepatitis on the background of obesity are characterized by lipid distress syndrome with an increase in total cholesterol in blood, low density proatherogenic lipoprotein, deficiency of anti-atherogenic high-density lipoproteins. The role of nitrosative stress in the pathogenesis of nonalcoholic steatohepatitis, the confirmation of which is the increase in the concentration of nitrosothiols, peroxynitrite and other metabolites NO in the blood. Conclusion. Thus, with the comorbid flow of non-alcoholic steatohepatitis and chronic kidney disease of the І-ІІ stage, on the background of obesity, a deeper lipid imbalance, hypercholesterolemia, including in the low density lipoprotein, a decrease in the content of high density lipoprotein, an increase in the atherogenicity index, and hyperproduction of the endothelium and lymphocytes from the progressive damage to the endothelium.


non-alcoholic steatohepatitis, chronic kidney disease, obesity, lipid profile, endothelial dysfunction


  1. Babak OYa, Kolesnikova EV, Syitnik KA. Profilakticheskie meropriyatiya pri nealkogolnoy zhirovoy bolezni pecheni: suschestvuet li sposob snizit risk razvitiya zabolevaniya? Suchasna gastroenterol. 2013;3(71):103-9. [in Russian].
  2. Bueverov AO, Bogomolov PO. Nealkogol’naya zhirovaya bolezn’ pecheni: obosnovanie patogeneticheskoy terapii. Klinicheskie perspektivy v gastroenterologii, gepatologii. 2009;1:3-9. [in Russian].
  3. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:330-44. PMID: 23507799. DOI: 10.1038/nrgastro.2013.41
  4. Baumgarten M, Gehr T. Chronic kidney disease: detection and evaluation. American Family Physician. 2011;84(10):1138-48.
  5. Brunt EM, Kleiner DE, Wilson LA, Belt P. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810-20.
  6. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am. J. Gastroenterol. 2012;107:811-26. 
  7. Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):666-75. PMID: 24061203. DOI: 10.1038/nrgastro.2013.175
  8. Cohen E, Nardi Y, Krause I, Goldberg E, Milo G, Garty M, et al. A longitudinal assessment of the natural rate of decline in renal function with age. J Nephrol. 2014;27(6):635-41. 
  9. Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity. Ann. Med. 2011;43:617-49.
  10. Nascimbeni F, Pais R, Bellentani S, Rafique M, Bansal V and Constantin J. From NAFLD in clinical practice to answers from guidelines. J. Hepatol. 2013;59(4):859-71. 

Publication of the article:

«Bulletin of problems biology and medicine» Issue 4 part 1 (146), 2018 year, 45-47 pages, index UDK 616.36-003.826:616.379-008.64]:577.12+616.61-036.12